World-class teaching hospital is studying obstructive sleep apnea in multiple sclerosis

Photo by Kinga Cichewicz

Beth Israel Deaconess Medical Center started a new clinical trial of prevalence and impact of obstructive sleep apnea in multiple sclerosis (SOMNUS).

This study will evaluate the influence of sleep apnea on clinical and radiological features of MS. Sleep apnea is associated with hypoxemia during sleep, which we believe is detrimental to MS. The researchers will examine clinical data (MRI, lab results, medical history, labs, and sleep studies) of Dr. Sloane's MS patients. This will allow them to study correlations between MRI, clinical data, lab studies and sleep studies.

This is observational study. It began in June 2019 and will continue for the next three years.

Among study population are patients with multiple sclerosis with obstructive sleep apnea.

A total of 800 people will take part in this study.

Beth Israel Deaconess Medical Center (Boston, Massachusetts, United States, 02215) is the recruitment location.

Beth Israel Deaconess Medical Center (BIDMC) is a teaching hospital of Harvard Medical School. Among independent teaching hospitals, Beth Israel Deaconess Medical Center consistently ranks in the top three recipients of biomedical research funding from the National Institutes of Health. Research funding totals nearly $200 million annually.

For more details please check the study details here: https://ichgcp.net/clinical-trials-registry/NCT04603196